Influenza VaccinationNCT07864597
Family Physician Nudges for Influenza Vaccination Among Older Adults
A study testing Family Physician Influenza Vaccination Nudge in people with Influenza Vaccination, run by Fudan University.
Trial summary
The goal of this clinical trial is to learn if a family-physician nudge intervention works to improve influenza vaccination among adults aged 55 years and older in China. Three independent, parallel cluster randomized controlled trials will be conducted under three distinct vaccine payment policies, i.e. Read more about this study
- Who is it for?
- Ages 55 years and olderHealthy volunteers can take part
- Conditions the study is for
- Influenza Vaccination
- What is being tested?
- Family Physician Influenza Vaccination Nudge
- Type of treatment
- Vaccines, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 5,250 participants
- Where
- No sites listed yet
- Study dates
- 8 Oct 2026to Jun 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age ≥ 55 years.
- Not vaccinated against influenza in the current flu season.
- No contraindications to influenza vaccination.
- Willing and able to provide informed consent and participate in the study.
Who cannot join
- Age under 55 years.
- Has already received influenza vaccination in the current flu season.
- Has a known contraindication to influenza vaccination.
- Unable to comply with study procedures.
- Unwilling or unable to provide informed consent.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Family Physician Nudges for Influenza Vaccination Among Older Adults: Cluster Randomized Trials
The goal of this clinical trial is to learn if a family-physician nudge intervention works to improve influenza vaccination among adults aged 55 years and older in China. Three independent, parallel cluster randomized controlled trials will be conducted under three distinct vaccine payment policies, i.e. free vaccination for those older than 65 years and self-paid vaccination for those <65 years in rural areas, and partially insurance-covered vaccination in urban areas.
The main questions it aims to answer are:
Read more
- Does the family-physician nudge intervention increase influenza vaccination uptake among older adults? How does the effectiveness of the nudge intervention vary under different payment policies?
- Is the family-physician nudge intervention cost-effective, acceptable, feasible, and potentially sustainable in primary care settings? Researchers will compare an intervention group receiving a family-physician nudge with a control group receiving routine care to see if the nudge is effective at increasing influenza vaccination among older adults.
Participants will:
- Be recruited at community health service centers and cluster-randomized by their family physicians into one of two groups.
- Receive either a physician nudge (provider recommendation by an endowment-framing educational pamphlet + default appointment + a follow-up reminder) or routine health education.
- Have their influenza vaccination status verified through the immunization information system at the end of the trial.
Read the detailed description
Influenza vaccination is the most effective measure for preventing influenza. However, the influenza vaccination rate in China is extremely low, with older adults, a high-risk group for influenza, having a vaccination rate of only about 4%. Beginning in 2026, China provides free influenza vaccination for adults aged 65 years and older in rural areas, and allows the personal accounts of employees' basic medical insurance to be used to pay for influenza vaccination for the account holders and their family members, thereby removing the economic barrier to vaccination. Under these payment policies, how to design effective behavioral intervention strategies to increase the vaccination rate has become an important issue.
This study proposes to conduct three independent, parallel cluster randomized controlled trials to implement a family-physician influenza vaccination nudge intervention among adults aged 55 years and older, and to evaluate the effect of the intervention on improving the influenza vaccination rate among older adults under three distinct payment policies. The three sub-trials are conducted under the free vaccination policy for adults aged 65 years and older in rural areas, the self-paid vaccination policy for adults aged 55-64 years in rural areas, and the partially insurance-covered vaccination policy for adults aged 55 years and older in urban areas, respectively. A health economic evaluation will be conducted concurrently, together with a feasibility evaluation based on semi-structured interviews, so as to empower family physicians to promote vaccination among older populations.
Sample sizes are calculated independently for the three sub-trials, based on the primary outcome measure (influenza vaccination uptake) and the main analysis method (comparison of rates between two groups). For the rural sub-trial (free-vaccine policy), taking 10% vaccination rate as the control-group baseline and assuming the nudge intervention raises the rate to 18% (an 8-percentage-point absolute increase), with α = 0.05 (two-sided) and ICC = 0.02, an average of 20 participants per cluster and 54 clusters (family physicians) are required to achieve the power of 90%, resulting in a total sample of 1,080 adults aged 65 years and older. For the rural sub-trial (out-of-pocket policy), taking 4% vaccination rate as the control-group baseline and assuming the intervention raises the rate to 8% (a 4-percentage-point increase, attenuated by economic factors), with the same α and ICC, and an average of 43 participants per cluster and 54 clusters (family physicians) are required to achieve the power of 85%, resulting in a total sample of 2,322 adults aged 55-64 years. For the urban sub-trial (out-of-pocket/insurance policy), taking 5% vaccination rate as the control-group baseline and assuming the intervention raises the rate to 10% (a 5-percentage-point increase, attenuated by economic factors), with the same α and ICC, and an average of 44 participants per cluster and 42 clusters (family physicians) are required to achieve the power of 85%, resulting in a total sample of 1,848 adults aged 55 years and older.
A cluster randomized controlled design will be employed across three representative regions in China. Taking the level of economic development into account, three provinces are selected from the eastern, central, and western regions, and in each province, 3-4 community health service centers (CHCs) are selected in urban and rural areas respectively. In total, 9-12 urban/rural CHCs are recruited, yielding approximately 42 urban and 54 rural family physician clusters. Older adults will be recruited during the primary care visits at the participating CHCs, where all eligible patients meeting inclusion criteria are invited to participate and provide informed consent.
Randomization is performed independently for each sub-trial, with the family physician as the cluster unit. The randomization sequence will be generated in advance by an independent statistician using a computer-generated random number method. Owing to the nature of the intervention, both family physicians and participants are aware of group assignment, and blinding cannot be fully implemented; however, local coordinators, outcome assessors, data managers, and statistical analysts are blinded to group allocation.
The intervention group receives a three-component nudge: (1) an endowment-framing educational pamphlet and verbal recommendation for influenza vaccination by the family physician; (2) on-site default appointment (opt-out) for vaccination; and (3) a telephone reminder at two weeks for those not yet vaccinated. The control group maintains the existing routine service model, with only standard influenza vaccination health education provided during routine encounters.
The intention-to-treat (ITT) approach is used as the primary analysis strategy. Influenza vaccination status at 1 month and 3 months is analyzed using generalized estimating equations (GEE) with the family physician as the clustering unit and the community health service center as a fixed effect, adjusting for prespecified covariates (region, sex, age, marital status, type of medical insurance in the urban sub-trial, and prior influenza vaccination history). Adjusted relative risk and absolute risk difference with 95% confidence intervals are reported. Time-to-vaccination is evaluated using Kaplan-Meier curves and Cox proportional hazards models with robust standard errors. Prespecified subgroup analyses assess heterogeneity of intervention effects. A per-protocol analysis serves as a sensitivity analysis. A health economic evaluation (cost-effectiveness with ICER calculation) and a feasibility evaluation via semi-structured interviews with family physicians and older adults are conducted alongside the trial.
- Conditions
- Influenza Vaccination
- Being tested
- Family Physician Influenza Vaccination Nudge
- Keywords
- influenza vaccination, nudge, family physician, clinical trial, older adults, behavioral science
- Medical subject headings
- Influenza, Human
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Family Physician Influenza Vaccination NudgeBehavioural
A family-physician-delivered behavioral nudge combines provider recommendation by an endowment-framing educational pamphlet, default appointment scheduling, and a follow-up reminder, which is designed to increase influenza vaccination uptake among older adults. Grounded in behavioral science theories of vaccination decision-making and nudging, the intervention leverages the high credibility of primary-care family physicians among older adults and reduces the behavioral frictions associated with seeking vaccination.
| Study group | Role | What they receive |
|---|---|---|
| Family Physician Nudge Group | Experimental | In addition to routine health education, participants in this arm receive a multicomponent nudge delivered by their family physician during a routine primary care encounter. The nudge consists of: (1) an endowment-framing educational pamphlet and verbal recommendation for influenza vaccination by the family physician; (2) on-site assistance with scheduling a vaccination appointment as the default (opt-out) option; and (3) a telephone reminder two weeks after the encounter for those who have not yet completed vaccination. The intervention is delivered during the 2026-2027 influenza vaccination season. Receives: Behavioral: Family Physician Influenza Vaccination Nudge |
| Routine Care Group | No intervention | Participants assigned to the control arm receive routine care - the family physician sees them per standard clinical procedures and provides only routine health education on influenza vaccination, without the deliberate use of the nudge intervention components (no structured recommendation, no default appointment, no two-week telephone reminder). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Influenza Vaccination Uptake
Whether participants get vaccinated against influenza, measured by official vaccination records.
Measured: 1 month and 3 months after the intervention
Secondary outcomes (1)
Timing of Influenza Vaccination
Number of days from the intervention date to receipt of influenza vaccination, measured by official vaccination records.
Measured: Within 3 months after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2026
- Study start8 Oct 2026 (estimated)
- Primary completionMar 2027 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Influenza VaccinationStudies of the same condition, open and under way.
- More trials run by Fudan UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 5,250 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fudan University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zhiyuan Hou, Fudan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07864597
- Sponsor's protocol ID
- Fudan Flu-vaccine Nudge
- Status last verified
- Oct 2026
- First submitted
- 2 Oct 2026
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared due to participant privacy concerns and institutional data protection policies. Aggregate study results will be published in peer-reviewed journals and disseminated through policy briefs.
Publications
Mehta SJ, Waddell KJ, Linn KA, Brophy C, Liang J, Park SH, Reitz C, Williams K, Couzens C, Staloff J, White AA, Rhodes C, Liao JM, Navathe AS. Nudges to Clinicians and Patients for Influenza Vaccines During Visits: The BE IMMUNE Randomized Clinical Trial. JAMA Intern Med. 2026 Mar 1;186(3):304-310. doi: 10.1001/jamainternmed.2025.7133.
PubMed 41490010Cao Y, Wang Q, Zhao J, Zhang Y, Huo R, Li Q, Yang W, Yi H, Feng L. Healthcare workers' attitudes toward influenza vaccine prescriptions in China. Glob Health Res Policy. 2025 Aug 4;10(1):34. doi: 10.1186/s41256-025-00430-0.
PubMed 40760695Kim RH, Day SC, Small DS, Snider CK, Rareshide CAL, Patel MS. Variations in Influenza Vaccination by Clinic Appointment Time and an Active Choice Intervention in the Electronic Health Record to Increase Influenza Vaccination. JAMA Netw Open. 2018 Sep 7;1(5):e181770. doi: 10.1001/jamanetworkopen.2018.1770.
PubMed 30646151Lehmann BA, Chapman GB, Franssen FM, Kok G, Ruiter RA. Changing the default to promote influenza vaccination among health care workers. Vaccine. 2016 Mar 8;34(11):1389-92. doi: 10.1016/j.vaccine.2016.01.046. Epub 2016 Feb 3.
PubMed 26851734Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong JYT, Yang J, Bond HS, Wang L, Lau YC, Zheng J, Feng S, Qin Y, Fang VJ, Jiang H, Lau EHY, Liu S, Qi J, Zhang J, Yang J, He Y, Zhou M, Cowling BJ, Feng L, Yu H. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health. 2019 Sep;4(9):e473-e481. doi: 10.1016/S2468-2667(19)30163-X.
PubMed 31493844